U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C40H71NO14.C12H26O4S
Molecular Weight 1056.387
Optical Activity UNSPECIFIED
Defined Stereocenters 18 / 18
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ERYTHROMYCIN ESTOLATE

SMILES

CCCCCCCCCCCCOS(O)(=O)=O.[H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]2[C@H](C)[C@@H](O[C@]3([H])O[C@H](C)C[C@@H]([C@H]3OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]2C

InChI

InChIKey=AWMFUEJKWXESNL-JZBHMOKNSA-N
InChI=1S/C40H71NO14.C12H26O4S/c1-15-27-40(11,48)33(44)22(5)30(43)20(3)18-38(9,47)35(55-37-32(53-28(42)16-2)26(41(12)13)17-21(4)50-37)23(6)31(24(7)36(46)52-27)54-29-19-39(10,49-14)34(45)25(8)51-29;1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15/h20-27,29,31-35,37,44-45,47-48H,15-19H2,1-14H3;2-12H2,1H3,(H,13,14,15)/t20-,21-,22+,23+,24-,25+,26+,27-,29+,31+,32-,33-,34+,35-,37+,38-,39-,40-;/m1./s1

HIDE SMILES / InChI
Molecular Formula C40H71NO14
Molecular Weight 789.99
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 18 / 18
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula C12H26O4S
Molecular Weight 266.397
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:02:12 UTC 2023
Edited
by admin
on Fri Dec 15 15:02:12 UTC 2023
Record UNII
XRJ2P631HP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ERYTHROMYCIN ESTOLATE
EP   MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN  
Official Name English
ERYTHROMYCIN ESTOLATE [VANDF]
Common Name English
ERYTHROMYCIN ESTOLATE [MI]
Common Name English
ERYTHROMYCIN 2'-PROPIONATE DODECYL SULPHATE (SALT).
Common Name English
ERYTHROMYCIN ESTOLATE [USAN]
Common Name English
ERYTHROMYCIN ESTOLATE [USP-RS]
Common Name English
ERYTHROMYCIN ESTOLATE [EP MONOGRAPH]
Common Name English
ERYTHROMYCIN ESTORATE
Common Name English
ERYTHROMYCIN ESTOLATE [MART.]
Common Name English
ERYTHROMYCIN, 2'-PROPANOATE, DODECYL SULPHATE (SALT)
Common Name English
Erythromycin estolate [WHO-DD]
Common Name English
ERYTHROMYCIN, 2'-PROPANOATE, DODECYL SULFATE (SALT)
Common Name English
NSC-263364
Code English
ERYTHROMYCIN ESTOLATE [USP MONOGRAPH]
Common Name English
ERYTHROMYCIN ESTOLATE COMPONENT OF ILOSONE SULFA
Common Name English
ERYTHROMYCIN ESTOLATE [ORANGE BOOK]
Common Name English
ERYTHROMYCIN ESTORATE [JAN]
Common Name English
ILOSONE
Brand Name English
ERYTHROMYCIN 2'-PROPIONATE DODECYL SULFATE (SALT).
Common Name English
ERYTHROMYCIN (AS ESTOLATE)
Common Name English
ILOSONE SULFA COMPONENT ERYTHROMYCIN ESTOLATE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C261
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
Code System Code Type Description
PUBCHEM
441371
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
CAS
3521-62-8
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
RS_ITEM_NUM
1243002
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
MESH
D004918
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
DRUG BANK
DBSALT001358
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
RXCUI
4055
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY RxNorm
CHEBI
4846
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
MERCK INDEX
m5010
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY Merck Index
FDA UNII
XRJ2P631HP
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
EVMPD
SUB01941MIG
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
ECHA (EC/EINECS)
222-532-4
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
ChEMBL
CHEMBL2220427
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
EPA CompTox
DTXSID1037224
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
NCI_THESAURUS
C47986
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
NSC
263364
Created by admin on Fri Dec 15 15:02:12 UTC 2023 , Edited by admin on Fri Dec 15 15:02:12 UTC 2023
PRIMARY
Related Record Type Details
Structure of Erythromycin
BASIS OF STRENGTH->SUBSTANCE
BIOASSAY (CYLINDER PLATE)
USP
Structure of ERYTHROMYCIN ESTOLATE
BASIS OF STRENGTH->SUBSTANCE
ASSAY (HPLC)
EP
Structure of ERYTHROMYCIN PROPIONATE
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of PSEUDOERYTHROMYCIN A ENOL ETHER
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 0.15
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of ERYTHROMYCIN A ENOL ETHER
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 0.09
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of N-DEMETHYL-N-PROPANOYLERYTHROMYCIN A
IMPURITY -> PARENT
For the calculation of contents, multiply the peak areas by 0.14
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of ERYTHROMYCIN F
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of ERYTHROMYCIN E
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of N-DEMETHYLERYTHROMYCIN A
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of ANHYDROERYTHROMYCIN A
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
Structure of Erythromycin
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966